Everyone now acknowledges that the health insurance exchanges aren’t working out quite like planned. Soon we may have some useful research on why that happened, but now we are still getting analyses revealing the depth of the problem, including one from the Brookings Institution that examined exchanges in six states. (Brookings Analysis) Here is what the authors found, based not just on looking at data but talking to stakeholders in each state. In Alaska there are only two competitors on the exchange and premiums are high. But Alaska is probably a special case, extremely rural and a low population and not much competition in the provider market. As in other states, the interviewees also emphasized low consumer knowledge and high confusion. In Florida there is a fair amount of competition in some areas, but premiums are high where there isn’t. Stakeholders identified ability to negotiate with providers as a key to lower prices. Kansas had relatively low premiums but expectations were for a 30% to 40% increase this year. There is not a great deal of competition, basically only two insurers selling on the exchange, but provider prices may be low enough to constrain premiums. North Carolina experienced low competition in the first year, but competition has grown, with insurers using narrower networks, tiered plans and provider risk-sharing to enhance their comfort with offering plans without losing their shirts. But as elsewhere, rural areas tend to have no competition and high premiums. Ohio had a number of health plan participants in most areas, but still had high premiums, which the stakeholders attributed to high provider pricing and little ability to negotiate. Texas had adequate competition and somewhat lower premiums. The common thread is a difficulty in attracting enough competition to all areas of a state, provider pricing and leverage that limits lowering of premiums, and low levels of consumer knowledge.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
IBM ending a huge bust in its health care efforts, selling its Watson health care assets to a PE firm. IBM spent a fortune building this and claimed it would...
January 21, 2022
More lunacy, kind of ironic for a mental health company, as Lyra Health raises a fresh $235 million in capital at over a $5 billion valuation. Just gonna say the...
January 20, 2022
More froth in the capital markets as R1 RCM pays $4.1 billion for CloudMed. R1 RCM helps health care providers with billing and other practice management software and services and...
January 12, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace